317 related articles for article (PubMed ID: 18370964)
1. Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.
Gilman BH; Kautter J
Health Serv Res; 2008 Apr; 43(2):478-95. PubMed ID: 18370964
[TBL] [Abstract][Full Text] [Related]
2. Consumer response to dual incentives under multitiered prescription drug formularies.
Gilman BH; Kautter J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
[TBL] [Abstract][Full Text] [Related]
3. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
Cecil WT; Barnes J; Shea T; Coulter SL
J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
[TBL] [Abstract][Full Text] [Related]
4. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
5. Employer drug benefit plans and spending on prescription drugs.
Joyce GF; Escarce JJ; Solomon MD; Goldman DP
JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
[TBL] [Abstract][Full Text] [Related]
6. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
Klepser DG; Huether JR; Handke LJ; Williams CE
J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
[TBL] [Abstract][Full Text] [Related]
7. Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroids.
Meissner BL; Moore WM; Shinogle JA; Reeder CE; Little JM
J Manag Care Pharm; 2004; 10(3):226-33. PubMed ID: 15228372
[TBL] [Abstract][Full Text] [Related]
8. Medicare program; Medicare prescription drug benefit. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
[TBL] [Abstract][Full Text] [Related]
9. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
Johnson JT; Neill KK; Davis DA
J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
[TBL] [Abstract][Full Text] [Related]
10. In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions.
Hoadley JF; Merrell K; Hargrave E; Summer L
Health Aff (Millwood); 2012 Oct; 31(10):2266-75. PubMed ID: 23048108
[TBL] [Abstract][Full Text] [Related]
11. Prescription drugs: issues of cost, coverage, and quality.
Copeland C
EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
[TBL] [Abstract][Full Text] [Related]
12. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
13. Trends in the prescription drug plans delivering the Medicare Part D prescription drug benefit.
Brill JV
Am J Health Syst Pharm; 2007 Aug; 64(15 Suppl 10):S3-6; quiz S21-S23. PubMed ID: 17646551
[TBL] [Abstract][Full Text] [Related]
14. Drug plan design incentives among Medicare prescription drug plans.
Huskamp HA; Keating NL; Dalton JB; Chernew ME; Newhouse JP
Am J Manag Care; 2014 Jul; 20(7):562. PubMed ID: 25295402
[TBL] [Abstract][Full Text] [Related]
15. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.
Mager DE; Cox ER
Am J Manag Care; 2007 Jun; 13(6 Pt 2):347-52. PubMed ID: 17567235
[TBL] [Abstract][Full Text] [Related]
16. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
Buttorff C; Andersen MS; Riggs KR; Alexander GC
Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
[TBL] [Abstract][Full Text] [Related]
17. Retiree health benefits.
Morrisey MA
Annu Rev Public Health; 1993; 14():271-92. PubMed ID: 8323590
[TBL] [Abstract][Full Text] [Related]
18. Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program.
Bishop CE; Ryan AM; Gilden DM; Kubisiak J; Thomas CP
Health Serv Res; 2009 Jun; 44(3):1010-28. PubMed ID: 19291168
[TBL] [Abstract][Full Text] [Related]
19. Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts.
Elliott MN; Landon BE; Zaslavsky AM; Edwards C; Orr N; Beckett MK; Mallett J; Cleary PD
Health Aff (Millwood); 2016 Mar; 35(3):456-63. PubMed ID: 26953300
[TBL] [Abstract][Full Text] [Related]
20. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
